Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Amortizatization of Intangibles: 2020-2025

Historic Amortizatization of Intangibles for Journey Medical (DERM) over the last 5 years, with Sep 2025 value amounting to $1.1 million.

  • Journey Medical's Amortizatization of Intangibles rose 30.71% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year increase of 28.15%. This contributed to the annual value of $3.4 million for FY2024, which is 9.11% down from last year.
  • Journey Medical's Amortizatization of Intangibles amounted to $1.1 million in Q3 2025, which was down 0.00% from $1.1 million recorded in Q2 2025.
  • Journey Medical's Amortizatization of Intangibles' 5-year high stood at $1.2 million during Q4 2022, with a 5-year trough of $572,000 in Q4 2021.
  • Moreover, its 3-year median value for Amortizatization of Intangibles was $981,000 (2024), whereas its average is $943,909.
  • Per our database at Business Quant, Journey Medical's Amortizatization of Intangibles surged by 114.51% in 2022 and then slumped by 33.58% in 2023.
  • Over the past 5 years, Journey Medical's Amortizatization of Intangibles (Quarterly) stood at $572,000 in 2021, then surged by 114.51% to $1.2 million in 2022, then tumbled by 33.58% to $815,000 in 2023, then grew by 20.37% to $981,000 in 2024, then spiked by 30.71% to $1.1 million in 2025.
  • Its Amortizatization of Intangibles was $1.1 million in Q3 2025, compared to $1.1 million in Q2 2025 and $1.1 million in Q1 2025.